1. Home
  2. NKGN vs ZAPP Comparison

NKGN vs ZAPP Comparison

Compare NKGN & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • ZAPP
  • Stock Information
  • Founded
  • NKGN 2017
  • ZAPP 2017
  • Country
  • NKGN United States
  • ZAPP Thailand
  • Employees
  • NKGN N/A
  • ZAPP N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • ZAPP Motor Vehicles
  • Sector
  • NKGN Health Care
  • ZAPP Consumer Discretionary
  • Exchange
  • NKGN Nasdaq
  • ZAPP Nasdaq
  • Market Cap
  • NKGN 14.1M
  • ZAPP 6.2M
  • IPO Year
  • NKGN N/A
  • ZAPP N/A
  • Fundamental
  • Price
  • NKGN $0.65
  • ZAPP $1.30
  • Analyst Decision
  • NKGN
  • ZAPP
  • Analyst Count
  • NKGN 0
  • ZAPP 0
  • Target Price
  • NKGN N/A
  • ZAPP N/A
  • AVG Volume (30 Days)
  • NKGN 570.0K
  • ZAPP 158.7K
  • Earning Date
  • NKGN 12-24-2024
  • ZAPP 12-31-2024
  • Dividend Yield
  • NKGN N/A
  • ZAPP N/A
  • EPS Growth
  • NKGN N/A
  • ZAPP N/A
  • EPS
  • NKGN N/A
  • ZAPP N/A
  • Revenue
  • NKGN N/A
  • ZAPP N/A
  • Revenue This Year
  • NKGN N/A
  • ZAPP N/A
  • Revenue Next Year
  • NKGN N/A
  • ZAPP $53,347.33
  • P/E Ratio
  • NKGN N/A
  • ZAPP N/A
  • Revenue Growth
  • NKGN N/A
  • ZAPP N/A
  • 52 Week Low
  • NKGN $0.20
  • ZAPP $0.70
  • 52 Week High
  • NKGN $4.06
  • ZAPP $19.10
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 65.93
  • ZAPP 28.94
  • Support Level
  • NKGN $0.45
  • ZAPP $1.32
  • Resistance Level
  • NKGN $0.62
  • ZAPP $1.87
  • Average True Range (ATR)
  • NKGN 0.08
  • ZAPP 0.17
  • MACD
  • NKGN 0.01
  • ZAPP -0.00
  • Stochastic Oscillator
  • NKGN 70.95
  • ZAPP 6.15

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About ZAPP Zapp Electric Vehicles Group Limited

Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.

Share on Social Networks: